VivoZ Biolabs

VivoZ Biolabs Overview

  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $50K
Latest Deal Amount
  • Investors
  • 2

VivoZ Biolabs General Information


Developer of cell culture platforms intended to mimic dynamic 3D tumor micro-environment. The company's cell culture platforms offers accurate anti-cancer drug screening on patient's own biopsy samples for drug response prior to the administration of cancer therapy, enabling cancer patients to improve patients life quality.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare
Primary Office
  • 160 Convent Avenue
  • Steinman Hall, RM T-142
  • New York, NY 10031
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

VivoZ Biolabs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 01-Jan-2015 $50K Completed Startup
1. Grant 31-Dec-2013 0000 Completed Startup

VivoZ Biolabs Executive Team (3)

Name Title Board Seat Contact Info
Zeynep Direli Korkut Co-Founder & Chief Executive Officer
Sihong Wang Co-Founder
Xuejun Jiang Co-Founder

VivoZ Biolabs Investors (2)

To view VivoZ Biolabs‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Zahn Innovation Platform Launchpad Accelerator/Incubator 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0

Ready to get started?

Request a free trial